The purpose of this study is to determine whether treatment with daily oral dose of AZD8529 40 mg administered over 28 days is safe, well tolerated and improves main symptoms of schizophrenia in adult schizophrenia patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
PANSS Total Score
Timeframe: Prior to randomization (screening, admission to washout/run in, baseline) and Days 8, 15, 22, and 28